Dallas Matthew D 4
4 · AVEO PHARMACEUTICALS INC · Filed Feb 8, 2019
Insider Transaction Report
Form 4
Dallas Matthew D
VP, Finance
Transactions
- Award
Stock Option (right to buy)
2019-02-06+450,750→ 450,750 totalExercise: $0.62Exp: 2029-02-06→ Common Stock (450,750 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in equal monthly installments from February 6, 2019 through February 6, 2023, subject to the Reporting Person's continued service to the Company.